High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients.
By M. Zelefsky, Z. Fuks, Margie Hunt, Y. Yamada, C. Marion, C. Ling, H. Amols, E. Venkatraman, StevenA Leibel. International Journal of Radiation Oncology, Biology, Physics, 2002
844 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Radiation
View Paper: https://www.semanticscholar.org/paper/71f34f6c1d90309cca965420639bcfaac122ae75
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pulmonary and Respiratory Medicine
In Radiation
Citations in the corpus
- Particle radiation therapy using proton and heavier ion beams. (2007, result): “Results of this study are still being awaited and will have to be measured against results obtained most recently with modern photon IMRT.(61) The main question is whether proton RT permits higher radiation doses to the prostate at the same toxicity level as photon IMRT.”
- Advances in Radiation Therapy: Conventional to 3D, to IMRT, to 4D, and Beyond (2005, methodology): “29 Sequential dose escalation studies conducted at Memorial Sloan Kettering Cancer Center support the notion that the use of IMRT can reduce morbidity compared with 3D CRT. 30 In their analysis of over 772 patients who received doses in excess of 81 Gy (roughly 20% higher doses conventionally used i”
- Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. (2004, neutral): “Follow-up after radiotherapy, median (range), mo 45 (1-180)”
- Volumetric modulated arc therapy: a review of current literature and clinical use in practice. (2011, background): “The use of IMRT allows dose escalation, which has been shown to improve clinical outcomes while simultaneously reducing toxicity by improved OAR sparing [8, 44–50].”